The detectable number of small vesicles with specific protein cargo, including FAK and EGFR, have been found to be increased in patients with breast cancer compared to healthy controls, as have exosomal expression of splice variants of a pro-apoptotic protein called Survivin [73,74]. This evidence concerns the gene EGFR and breast carcinoma.